Has Kimberly Kenton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,453 in general payments to Kimberly Kenton, MD across 87 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Kenton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Kenton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Kenton, MD

Urogynecology and Reconstructive Pelvic Surgery · Chicago, ILNPI 1629042759

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Axonics, Inc. at 48.9% of the total. Reporting peaked in 2024 at $21,366 and has fallen 78.9% since, to $4,509 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,453in general payments, 2019–2025

Across 87 payments — averaging $499.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axonics, Inc.$21K
Boston Scientific$12K
CMR Surgical, Inc.$4K
Intuitive Surgical$4K
Coloplast$709
Renovia Inc$359
plus $258 from 3 others

$51,604in research payments, 2019–2025

Across 128 payments — averaging $403.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Axonics, Inc.$40K
Bluewind Medical$9K
Astellas Pharma Global Development$3K

What the payments were for

Consulting fees$22,56452%
Travel & lodging$13,89632%
Food & beverage$3,9939%
Education$3,0007%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axonics, Inc.	28	$21,236
Boston Scientific	24	$12,490
CMR Surgical, Inc.	3	$4,353
Intuitive Surgical	19	$4,048
Coloplast	6	$709
Renovia Inc	1	$359
Baxter Healthcare	2	$140
Medtronic	3	$67
Applied Medical Resources Corporation	1	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Axonics$20,514
GENERAL - THERAPIES$11,245
Versius Surgical System (Versius Plus)$4,313
Da Vinci Surgical System$3,443
Bulkamid$1,464
ALTIS$431
Leva Pelvic Floor Trainer$359
Advantage System$282
SOLYX$233
RESTORELLE$165
Solyx SIS System$113

How this compares

$43,453 in reported general payments places this provider in the 90th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.

See all urogynecology and reconstructive pelvic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$111,401

Medicare patients

150

Services billed

1,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
GemtesaVibegron	20	$12,788
MyrbetriqMirabegron	14	$6,600
Estradiol	13	$621
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	31	$301
Ibuprofen	22	$52
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	16	$35

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Chicago

Abraham ShashouaChicago$339K
Akira GillinghamChicago$58K
Traci BeckChicago$32K
Margaret MuellerChicago$26K
Carol BretschneiderChicago$14K
Trieu DoChicago$11K
Sean GeorgeChicago$9K
Thythy PhamChicago$8K
Ankita GuptaChicago$7K
Sarah AdelsteinChicago$6K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →